tm logo

Monitor this mark

View On USPTO

SELICIDE
Live/Pending
FINAL REFUSAL - MAILED

mailed

on 16 Dec 2024

Last Applicant/ Owned by

Villya LLC

Suite 130-194

Melbourne

FL

32940

Serial Number

98571027 filed on 28th May 2024

Registration Number

N/A

Correspondent Address

Anna King

Anna King Banner Witcoff, Ltd.

Suite 3600

Chicago, IL 60606

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SELICIDE

Pharmaceuticals for the treatment of schistosomiasis; praziquantel

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals for the treatment of schistosomiasis; praziquantel

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98571027

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 009362.00047

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
17th Dec 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
17th Dec 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
17th Dec 2024TEAS/EMAIL CORRESPONDENCE ENTERED
16th Dec 2024NOTIFICATION OF FINAL REFUSAL EMAILED
16th Dec 2024FINAL REFUSAL WRITTEN
16th Dec 2024FINAL REFUSAL E-MAILED
12th Dec 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
12th Dec 2024TEAS/EMAIL CORRESPONDENCE ENTERED
12th Dec 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
10th Dec 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED